ts-1
Showing 1 - 9 of 9
Gastric Cancer Trial in Japan (Pembrolizumab, Oxaliplatin, TS-1)
Completed
- Gastric Cancer
- Pembrolizumab
- +3 more
-
Kashiwa, Chiba, Japan
- +24 more
Jun 3, 2021
Advanced Biliary Tract Cancer Trial in Taiwan (TS-1, Gemcitabine, Nivolumab)
Active, not recruiting
- Advanced Biliary Tract Cancer
- TS-1
- +2 more
-
Kaohsiung, Taiwan
- +5 more
Dec 7, 2021
Pancreatic Cancer Stage III, Pancreatic Cancer Stage IV Trial in Japan (TBI-1401(HF10), Gemcitabine, Nab-paclitaxel)
Active, not recruiting
- Pancreatic Cancer Stage III
- Pancreatic Cancer Stage IV
- TBI-1401(HF10)
- +3 more
-
Nagoya, Aichi, Japan
- +7 more
Mar 31, 2021
Pancreatic Cancer Trial in Japan, Taiwan (Gemcitabine plus TS-1, TS-1, Gemcitabine)
Completed
- Pancreatic Cancer
- Gemcitabine plus TS-1
- +2 more
-
Tokyo, Japan
- +11 more
Nov 1, 2012
Gastric Cancer Trial in 2-1-1, Asamizodai, Sagamihara (TS-1 and cisplatin, TS-1)
Completed
- Gastric Cancer
- TS-1 and cisplatin
- TS-1
-
2-1-1, Asamizodai, Sagamihara, Kanagawa, JapanEast Hospital, Kitasato University
Jul 6, 2011
Gastric Cancer Trial in Sapporo (Taxotere, TS-1)
Suspended
- Gastric Cancer
- Taxotere
- TS-1
-
Sapporo, Hokkaido, JapanHokkaido University Hospital (Hokkaido University Graduate Schoo
May 24, 2010
Colorectal Cancer Trial in Sapporo (Campto, Topotesin, TS-1)
Unknown status
- Colorectal Cancer
- Campto, Topotesin
- TS-1
-
Sapporo, Hokkaido, JapanHokkaido University Hospital
Oct 31, 2007
Metastatic Colorectal Cancer Trial in Sapporo (Campto, Topotesin, TS-1, L-Plat)
Suspended
- Metastatic Colorectal Cancer
- Campto, Topotesin
- +4 more
-
Sapporo, Hokkaido, JapanHokkaido University Hospital (Hokkaido University Graduate Schoo
Oct 31, 2007